Company Description
Sesen Bio, Inc. engages in designing, engineering, and developing targeted protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company...
Sesen Bio, Inc. engages in designing, engineering, and developing targeted protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.
Valuation
P/E Ratio (with extraordinary items)
1.92
Price to Sales Ratio
5.60
Price to Book Ratio
0.95
Enterprise Value to EBITDA
2.08
Enterprise Value to Sales
-2.63
Efficiency
Total Asset Turnover
0.11
Liquidity
Current Ratio
17.77
Quick Ratio
17.77
Cash Ratio
14.06
Profitability
Gross Margin
99.68
Operating Margin
-106.09
Pretax Margin
-32.43
Net Margin
-1.27
Return on Assets
-0.13
Return on Equity
-0.41
Return on Total Capital
-34.66
Capital Structure
Officers and Executives
| Name | Age | Officer Since | Title |
|---|---|---|---|
| Dr. Thomas R. Cannell | 59 | 2018 | President, Chief Executive Officer & Director |
| Ms. Monica Forbes | 45 | 2019 | Chief Financial Officer & Vice President |
| Ms. Stephanie Vigue | - | 2022 | Finance Director |
| Dr. Jeannick Cizeau | - | 2005 | Head of Research |
| Mr. Chèrie Kaefring | - | 2021 | Director-Clinical Operations |
Insider Actions
| 02/18/2022 |
Thomas R. Cannell President and CEO; Director |
606,800 | Award at $0 per share. | 0 |
| 02/18/2022 |
Monica Forbes Chief Financial Officer |
542,250 | Award at $0 per share. | 0 |
| 02/18/2022 |
Mark R. Sullivan General Counsel & Secretary |
339,525 | Award at $0 per share. | 0 |
| 02/18/2022 |
Glen C. MacDonald Chief Technology Officer |
308,925 | Award at $0 per share. | 0 |
| 02/18/2022 |
Elly Ryu Principal Accounting Officer |
86,300 | Award at $0 per share. | 0 |
| 10/01/2021 |
Elly Ryu Principal Accounting Officer |
115,000 | Award at $0 per share. | 0 |
MarketWatch News on SESN
Other News on SESN
-
- Edgar Online - (EDG = 10Q, 10K)
-
- Edgar Online - (EDG = 10Q, 10K)
-
- Seeking Alpha
- Loading more headlines...
